Assessment of cardiovascular events in a real-world high-risk cohort with type 2 diabetes or atheroscleortic cardiovascular disease in Germany

被引：0
|
作者：
Verket, M. [1 ]
Kossack, N. [2 ]
Brandts, J. [1 ]
Schoenfelder, T. [2 ,3 ]
Schuett, K. [1 ]
Haeckl, D. [2 ,4 ]
Marx, N. [1 ]
Mueller-Wieland, D. [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Aachen, Germany
[2] WIG2 Sci Inst Hlth Econ & Hlth Syst Res, Leipzig, Germany
[3] Tech Univ Dresden, Med Fac, Chair Hlth Sci Publ Hlth, Dresden, Germany
[4] Univ Leipzig, Fac Econ & Management Sci, Leipzig, Germany
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
876
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [31] Effect of testosterone therapy on cardiovascular risk factors, major adverse cardiovascular events and mortality in men with functional hypogonadism and cardiovascular disease in a real-world registry
    Saad, F.
    Haider, A.
    Haider, K. S.
    Doros, G.
    Traish, A. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3221 - 3221
  • [32] Lipoprotein(a) concentration is associated with risk of type 2 diabetes and cardiovascular events in a Chinese population with very high cardiovascular risk
    Muhanhali, Dilidaer
    Zhai, Tianyu
    Cai, Zhenqin
    Ling, Yan
    ENDOCRINE, 2020, 69 (01) : 63 - 72
  • [33] Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease
    Norgaard, Caroline H.
    Starkopf, Liis
    Gerds, Thomas A.
    Malmborg, Morten
    Bonde, Anders N.
    Zareini, Bochra
    Mills, Elisabeth Helen Anna
    Vestergaard, Peter
    Wong, Nathan D.
    Torp-Pedersen, Christian
    Lee, Christina J-Y
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (02)
  • [34] No Increased Risk of Cardiovascular Events with Dapagliflozin in Elderly Patients with Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Johansson, Peter A.
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A4 - A4
  • [35] Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity
    Song, S. H.
    Hardisty, C. A.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2008, 101 (11) : 875 - 879
  • [36] Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease
    Rana, Jamal S.
    Liu, Jennifer Y.
    Moffet, Howard H.
    Sanchez, Robert J.
    Khan, Irfan
    Karter, Andrew J.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (02): : 200 - 206
  • [37] Estimated risk of atherosclerotic cardiovascular disease and heart failure in type 2 diabetes without previous cardiovascular events
    Cannistraci, R.
    Pozzoli, M.
    Ciardullo, S.
    Muraca, E.
    Manzoni, G.
    Perra, S.
    Zerbini, F.
    Bianconi, E.
    Mortara, A.
    Lattuada, G.
    Perseghin, G.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 340 - 340
  • [38] No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension
    Gause-Nilsson, I.
    Sonesson, C.
    Johansson, P. A.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S362 - S363
  • [39] Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real-world study of patients followed for up to 19 years
    Coles, Briana
    Zaccardi, Francesco
    Hvid, Christian
    Davies, Melanie J.
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2021, 23 (01): : 218 - 227
  • [40] Cardiovascular risk assessment in type 2 diabetes mellitus
    Ebaa Al-Ozairi
    R. Jan-Willem Middelbeek
    Edward S. Horton
    Current Diabetes Reports, 2006, 6 (5)
12345